PHARMANIAGA Bhd reported a turnaround in the third quarter ended Sept 30, 2024 (3Q24), recording a net profit of RM101.03…
PHARMANIAGA Bhd has announced the resignation of PricewaterhouseCoopers PLT (PwC) as its external auditor. In a bourse filing today, the…
PHARMANIAGA Bhd’s independent auditors, PricewaterhouseCoopers PLT (PwC), have once again raised concerns about the company’s ability to continue operating as…
PHARMANIAGA Bhd narrowed its losses in the financial year ended Dec 31, 2023 (FY23) to RM77.45 million thanks to lower…
PHARMANIAGA Bhd’s subsidiary, Pharmaniaga Logistic Sdn Bhd (PLSB), has entered into a seven-year concession agreement with the Ministry of Health…
By RUPINDER SINGH In a move to fortify its financial position and make a decisive exit from Practice Note 17…
BURSA Malaysia has rejected Pharmaniaga Bhd’s appeal for a second standalone private placement proposal due to the company’s financial distress.…
by RUPINDER SINGH PHARMANIAGA Bhd’s proposed private placement II faced a setback as Bursa Securities rejected the proposal as a…
PHARMANIAGA Bhds wholly owned unit, Pharmaniaga LifeScience Sdn Bhd (PLS), has today entered into a memorandum of understanding (MoU) with…
by AZALEA AZUAR / pic TMR FILE SOME connected parties had attempted to take over beleaguered Phamaniaga Bhd on the cheap,…
PHARMANIAGA Bhd’s wholly owned subsidiary, Pharmaniaga Logistics Sdn Bhd, has recently been awarded a new medical supply logistics services contract…
PHARMANIAGA Bhd has received the green light from Bursa Securities for its proposed private placement exercise. In a stock exchange…
Pharmaniaga Bhd, a financially troubled company classified as a Practice Note 17 (PN17) entity, has clarified its intentions regarding the…